Mosaic disorders affecting pigmentation - part 1: how to make a clinical diagnosis.

Br J Dermatol

NHS England Rare Disease Collaborative Network for Mosaic Disorders, Paediatric Dermatology department, Great Ormond Street Hospital for Children, London, UK.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Mosaic disorders affecting pigmentation are a large group of different rare diseases which present with hypo- and/or hyper-pigmented birthmarks. These can carry associated risks such as involvement of other organ systems, a predisposition to cancer, and the possibility of transmission to future offspring as germline disease. However, clinical diagnosis of these conditions has been notoriously difficult, due not only to the rarity of the conditions, but to the similarity of their cutaneous signs and the massive intra-disease variability intrinsic to their pathogenetic mechanism. This review draws on the genetic and clinical discoveries of the last decade to introduce key concepts such as how to define a mosaic disorder, the relevance of small single pigmentary birthmarks, the occurrence of "post-natal birthmarks", and the defining clinical features of mosaic disorders affecting pigmentation. It then lays out a modular classification for use in clinical practice and research studies, based on two independently variable clinical features of the cutaneous signs - the developmental pattern, and the lesion type. The classification for the first time brings together macular lesions as well as naevi, epidermal as well as dermal lesions, and hyper- as well as hypo-pigmented, reflecting this unifying overview of the aetiology of birthmarks affecting pigmentation. A companion smartphone iOS app for the clinical classification has been designed for use in clinic and is freely available online at What'sThatSpot. The clinical importance of distinguishing mosaic disorders from germline disorders presenting with the same developmental patterns is discussed in the context of differential diagnoses. The third modular component of the classification - genotype - is addressed in the second part of this review.

Download full-text PDF

Source
http://dx.doi.org/10.1093/bjd/ljaf262DOI Listing

Publication Analysis

Top Keywords

mosaic disorders
16
disorders pigmentation
12
clinical
8
clinical diagnosis
8
cutaneous signs
8
clinical features
8
mosaic
5
pigmentation
4
pigmentation clinical
4
diagnosis mosaic
4

Similar Publications

Haemaphysalis leporispalustris (the rabbit tick) is one of the most broadly distributed hard tick species in the Americas. In 2018, investigators amplified DNA from a spotted fever group Rickettsia (SFGR) species found in host-seeking larvae and nymphs of H. leporispalustris collected in northern California and proposed the name Candidatus "Rickettsia lanei" using results obtained via multilocus sequence typing.

View Article and Find Full Text PDF

Background: Genetic modifiers are believed to play an important role in the onset and severity of polycystic kidney disease (PKD), but identifying these modifiers has been challenging due to the lack of effective methodologies.

Methods: We generated zebrafish mutants of IFT140, a skeletal ciliopathy gene and newly identified autosomal dominant PKD (ADPKD) gene, to examine skeletal development and kidney cyst formation in larval and juvenile mutants. Additionally, we utilized ift140 crispants, generated through efficient microhomology-mediated end joining (MMEJ)-based genome editing, to compare phenotypes with mutants and conduct a pilot genetic modifier screen.

View Article and Find Full Text PDF

Background: Turner syndrome (TS), also known as congenital ovarian hypoplasia, is one of the most common sex chromosome diseases in women. It is caused by the complete or partial deletion or structural change of one X chromosome in all or part of somatic cells. A rare case of karyotype Turner syndrome is reported.

View Article and Find Full Text PDF

Congenital heart disease (CHD) is the most common congenital anomaly. While surgical and interventional advancements have improved survival, the management of associated complications and comorbidities remains complex and would benefit from a personalised approach that more accurately predicts individualised risks and prognoses. Recently, next-generation sequencing has uncovered diverse genetic factors, including epigenetic modifications, somatic mosaicism and regulatory non-coding variants.

View Article and Find Full Text PDF